$34.7 Million is the total value of Telemetry Investments, L.L.C.'s 53 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | New | ALLERGAN PLC | $1,969,000 | – | 11,700 | +100.0% | 5.68% | – |
| ACIA | New | ACACIA COMMUNICATIONS INC | $392,000 | – | 6,000 | +100.0% | 1.13% | – |
| CBLK | New | CARBON BLACK INC | $338,000 | – | 13,000 | +100.0% | 0.98% | – |
| BID | New | SOTHEBYS | $224,000 | – | 3,925 | +100.0% | 0.65% | – |
| BAM | New | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $221,000 | – | 4,166 | +100.0% | 0.64% | – |
| GWR | New | GENESEE & WYO INCcl a | $221,000 | – | 2,000 | +100.0% | 0.64% | – |
| GCI | New | GANNETT CO INC | $189,000 | – | 17,600 | +100.0% | 0.54% | – |
| CDOR | New | CONDOR HOSPITALITY TR INC | $172,000 | – | 15,583 | +100.0% | 0.50% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $97,000 | – | 13,000 | +100.0% | 0.28% | – |
| ORMP | New | ORAMED PHARM INC | $32,000 | – | 10,000 | +100.0% | 0.09% | – |
| ARTX | New | AROTECH CORP | $29,000 | – | 10,000 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | 33 | Q4 2022 | 1.7% |
| AFFIMED N V | 31 | Q4 2022 | 3.9% |
| GLOBALSTAR INC | 30 | Q4 2022 | 2.5% |
| VIEWRAY INC | 23 | Q4 2022 | 2.1% |
| SPDR GOLD TRUST | 22 | Q4 2022 | 2.3% |
| ADMA BIOLOGICS INC | 21 | Q4 2022 | 2.9% |
| STEMLINE THERAPEUTICS INC | 21 | Q1 2020 | 1.2% |
| SPDR S&P 500 ETF TR | 20 | Q4 2022 | 53.9% |
| KADMON HLDGS INC | 19 | Q2 2021 | 7.0% |
| EIGER BIOPHARMACEUTICALS INC | 19 | Q4 2022 | 6.7% |
View Telemetry Investments, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Xtant Medical Holdings, Inc. | February 13, 2020 | 752,915 | 5.7% |
| Orexigen Therapeutics, Inc. | February 14, 2019 | 1,295,844 | 6.4% |
| Xtant Medical Holdings, Inc. | February 14, 2018 | 1,416,339 | 7.2% |
View Telemetry Investments, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-17 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Telemetry Investments, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.